VBI Total Revenue vs Total Current Liabilities Analysis

VBIVQ Stock

0.0005 0.00 0.000004%

VBI Vaccines financial indicator trend analysis is much more than just breaking down VBI Vaccines prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether VBI Vaccines is a good investment. Please check the relationship between VBI Vaccines Total Revenue and its Total Current Liabilities accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VBI Vaccines. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

To learn how to invest in VBI Stock, please use our How to Invest in VBI Vaccines guide.

Total Revenue vs Total Current Liabilities

Total Revenue vs Total Current Liabilities Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of VBI Vaccines Total Revenue account and Total Current Liabilities. At this time, the significance of the direction appears to have very strong relationship.

The correlation between VBI Vaccines' Total Revenue and Total Current Liabilities is 0.84. Overlapping area represents the amount of variation of Total Revenue that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of VBI Vaccines, assuming nothing else is changed. The correlation between historical values of VBI Vaccines' Total Revenue and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Revenue of VBI Vaccines are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Total Revenue i.e., VBI Vaccines' Total Revenue and Total Current Liabilities go up and down completely randomly.

Correlation Coefficient

0.84

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Total Revenue

Total revenue comprises all receipts VBI Vaccines generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Total Current Liabilities

Total Current Liabilities is an item on VBI Vaccines balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of VBI Vaccines are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most indicators from VBI Vaccines' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into VBI Vaccines current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VBI Vaccines. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

To learn how to invest in VBI Stock, please use our How to Invest in VBI Vaccines guide.As of 12/26/2024, Selling General Administrative is likely to grow to about 43.2 M. Also, Issuance Of Capital Stock is likely to grow to about 36 M

	2021	2022	2023	2024 (projected)
Interest Expense	5.1M	5.2M	8.1M	6.0M
Interest Income	372K	1.4M	1.7M	1.1M

Interest Expense Interest Income

VBI Vaccines fundamental ratios Correlations

	Short Long Term Debt	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Net Receivables	Good Will	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Lease Obligations	Inventory	Other Current Assets	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Capital Stock	Net Working Capital	Intangible Assets
Short Long Term Debt		-0.66	0.39	0.74	-0.69	0.52	-0.69	0.59	-0.46	-0.48	0.81	0.79	-0.58	-0.58	0.56	0.16	0.74	0.72	0.04	0.8	-0.72	0.77	-0.63	0.71	-0.65	-0.58
Total Assets	-0.66		0.01	-0.96	0.96	-0.34	0.94	-0.64	0.94	0.92	-0.73	-0.91	0.66	0.96	-0.91	0.29	-0.53	-0.97	0.55	-0.82	0.99	-0.86	0.97	-0.83	0.97	0.96
Other Current Liab	0.39	0.01		0.02	-0.11	0.73	-0.12	0.69	0.16	0.38	0.54	0.36	0.21	0.26	-0.3	0.95	0.66	0.21	0.8	0.52	-0.12	0.44	-0.01	0.2	0.01	0.24
Total Current Liabilities	0.74	-0.96	0.02		-0.92	0.32	-0.9	0.55	-0.81	-0.88	0.78	0.93	-0.77	-0.94	0.94	-0.25	0.6	0.94	-0.43	0.83	-0.97	0.85	-0.9	0.83	-0.92	-0.94
Total Stockholder Equity	-0.69	0.96	-0.11	-0.92		-0.56	1.0	-0.73	0.92	0.87	-0.84	-0.91	0.7	0.9	-0.8	0.2	-0.69	-0.94	0.45	-0.9	0.97	-0.94	0.99	-0.94	0.99	0.92
Property Plant And Equipment Net	0.52	-0.34	0.73	0.32	-0.56		-0.59	0.79	-0.3	-0.11	0.82	0.54	-0.31	-0.16	-0.01	0.51	0.91	0.45	0.33	0.78	-0.45	0.76	-0.49	0.72	-0.48	-0.21
Retained Earnings	-0.69	0.94	-0.12	-0.9	1.0	-0.59		-0.72	0.9	0.86	-0.85	-0.89	0.74	0.89	-0.77	0.2	-0.72	-0.92	0.44	-0.9	0.96	-0.94	0.99	-0.96	0.99	0.91
Accounts Payable	0.59	-0.64	0.69	0.55	-0.73	0.79	-0.72		-0.6	-0.33	0.79	0.8	-0.14	-0.41	0.29	0.48	0.75	0.77	0.11	0.87	-0.72	0.87	-0.69	0.67	-0.65	-0.44
Cash	-0.46	0.94	0.16	-0.81	0.92	-0.3	0.9	-0.6		0.92	-0.56	-0.75	0.53	0.91	-0.8	0.42	-0.37	-0.87	0.72	-0.68	0.9	-0.75	0.96	-0.76	0.94	0.93
Non Current Assets Total	-0.48	0.92	0.38	-0.88	0.87	-0.11	0.86	-0.33	0.92		-0.51	-0.7	0.75	0.99	-0.94	0.63	-0.3	-0.8	0.8	-0.59	0.87	-0.65	0.91	-0.75	0.92	0.99
Non Currrent Assets Other	0.81	-0.73	0.54	0.78	-0.84	0.82	-0.85	0.79	-0.56	-0.51		0.88	-0.66	-0.6	0.51	0.25	0.97	0.8	0.08	0.98	-0.81	0.96	-0.77	0.92	-0.78	-0.63
Long Term Debt	0.79	-0.91	0.36	0.93	-0.91	0.54	-0.89	0.8	-0.75	-0.7	0.88		-0.57	-0.8	0.77	0.09	0.74	0.98	-0.17	0.95	-0.96	0.95	-0.87	0.82	-0.87	-0.8
Net Receivables	-0.58	0.66	0.21	-0.77	0.7	-0.31	0.74	-0.14	0.53	0.75	-0.66	-0.57		0.76	-0.72	0.47	-0.57	-0.55	0.4	-0.59	0.66	-0.6	0.68	-0.82	0.74	0.77
Good Will	-0.58	0.96	0.26	-0.94	0.9	-0.16	0.89	-0.41	0.91	0.99	-0.6	-0.8	0.76		-0.97	0.52	-0.39	-0.88	0.7	-0.68	0.92	-0.73	0.93	-0.78	0.94	1.0
Common Stock Shares Outstanding	0.56	-0.91	-0.3	0.94	-0.8	-0.01	-0.77	0.29	-0.8	-0.94	0.51	0.77	-0.72	-0.97		-0.52	0.29	0.83	-0.65	0.59	-0.87	0.62	-0.82	0.65	-0.84	-0.95
Non Current Liabilities Total	0.16	0.29	0.95	-0.25	0.2	0.51	0.2	0.48	0.42	0.63	0.25	0.09	0.47	0.52	-0.52		0.4	-0.06	0.9	0.23	0.16	0.15	0.28	-0.12	0.31	0.51
Capital Lease Obligations	0.74	-0.53	0.66	0.6	-0.69	0.91	-0.72	0.75	-0.37	-0.3	0.97	0.74	-0.57	-0.39	0.29	0.4		0.63	0.28	0.91	-0.64	0.87	-0.6	0.84	-0.62	-0.42
Inventory	0.72	-0.97	0.21	0.94	-0.94	0.45	-0.92	0.77	-0.87	-0.8	0.8	0.98	-0.55	-0.88	0.83	-0.06	0.63		-0.35	0.89	-0.99	0.92	-0.93	0.81	-0.92	-0.88
Other Current Assets	0.04	0.55	0.8	-0.43	0.45	0.33	0.44	0.11	0.72	0.8	0.08	-0.17	0.4	0.7	-0.65	0.9	0.28	-0.35		-0.02	0.43	-0.12	0.55	-0.28	0.55	0.7
Total Liab	0.8	-0.82	0.52	0.83	-0.9	0.78	-0.9	0.87	-0.68	-0.59	0.98	0.95	-0.59	-0.68	0.59	0.23	0.91	0.89	-0.02		-0.89	0.99	-0.84	0.9	-0.84	-0.7
Net Invested Capital	-0.72	0.99	-0.12	-0.97	0.97	-0.45	0.96	-0.72	0.9	0.87	-0.81	-0.96	0.66	0.92	-0.87	0.16	-0.64	-0.99	0.43	-0.89		-0.92	0.96	-0.86	0.97	0.93
Property Plant And Equipment Gross	0.77	-0.86	0.44	0.85	-0.94	0.76	-0.94	0.87	-0.75	-0.65	0.96	0.95	-0.6	-0.73	0.62	0.15	0.87	0.92	-0.12	0.99	-0.92		-0.89	0.93	-0.89	-0.75
Total Current Assets	-0.63	0.97	-0.01	-0.9	0.99	-0.49	0.99	-0.69	0.96	0.91	-0.77	-0.87	0.68	0.93	-0.82	0.28	-0.6	-0.93	0.55	-0.84	0.96	-0.89		-0.9	1.0	0.94
Capital Stock	0.71	-0.83	0.2	0.83	-0.94	0.72	-0.96	0.67	-0.76	-0.75	0.92	0.82	-0.82	-0.78	0.65	-0.12	0.84	0.81	-0.28	0.9	-0.86	0.93	-0.9		-0.92	-0.81
Net Working Capital	-0.65	0.97	0.01	-0.92	0.99	-0.48	0.99	-0.65	0.94	0.92	-0.78	-0.87	0.74	0.94	-0.84	0.31	-0.62	-0.92	0.55	-0.84	0.97	-0.89	1.0	-0.92		0.96
Intangible Assets	-0.58	0.96	0.24	-0.94	0.92	-0.21	0.91	-0.44	0.93	0.99	-0.63	-0.8	0.77	1.0	-0.95	0.51	-0.42	-0.88	0.7	-0.7	0.93	-0.75	0.94	-0.81	0.96

Click cells to compare fundamentals

VBI Vaccines Account Relationship Matchups

Pair Trading with VBI Vaccines

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if VBI Vaccines position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VBI Vaccines will appreciate offsetting losses from the drop in the long position's value.

Moving together with VBI Stock

0.62

EMMA

Emmaus Life Sciences

Pair Corr

Moving against VBI Stock

0.53	EPRX	Eupraxia Pharmaceuticals	Pair Corr
0.48	GRCE	Grace Therapeutics, Symbol Change	Pair Corr
0.44	FBIOP	Fortress Biotech Pref	Pair Corr
0.39	FRTX	Fresh Tracks Therapeutics	Pair Corr
0.37	UPB	Upstream Bio,	Pair Corr

The ability to find closely correlated positions to VBI Vaccines could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace VBI Vaccines when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back VBI Vaccines - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling VBI Vaccines to buy it.

The correlation of VBI Vaccines is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as VBI Vaccines moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if VBI Vaccines moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for VBI Vaccines can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for VBI Stock Analysis

When running VBI Vaccines' price analysis, check to measure VBI Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VBI Vaccines is operating at the current time. Most of VBI Vaccines' value examination focuses on studying past and present price action to predict the probability of VBI Vaccines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VBI Vaccines' price. Additionally, you may evaluate how the addition of VBI Vaccines to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC